• Bradykinin B2 Receptors Regulate Ileal Peristalsis in Guinea

  2026-05-07

  This study delivers the first direct evidence that bradykinin inhibits the peristaltic reflex in the guinea pig ileum via B2 receptor activation. The findings clarify the receptor-specific regulation of intestinal motility and have implications for the selection and interpretation of ACE inhibitor models in hypertension and gastrointestinal research.

• Disulfiram: Synthetic Lethality and Proteasome Inhibition in

  2026-05-06

  Explore how Disulfiram, a dopamine β-hydroxylase inhibitor, enables synthetic lethality strategies in APC-deficient cancer models through proteasome inhibition and ROS pathway activation. This article delivers mechanistic insights and practical assay guidance for advanced cancer research.

• NU6300 Inhibits Gasdermin D-Mediated Pyroptosis via Cysteine

  2026-05-06

  The reference study identifies NU6300 as a covalent inhibitor of gasdermin D (GSDMD), targeting cysteine-191 to block GSDMD cleavage and palmitoylation, thereby suppressing pyroptotic cell death. These findings advance the understanding of inflammasome signaling modulation and provide a new chemical probe for dissecting pyroptosis and inflammation-related pathologies.

• HyperScribe T7 High Yield Cy5 RNA Labeling Kit: Workflow & O

  2026-05-05

  The HyperScribe T7 High Yield Cy5 RNA Labeling Kit from APExBIO streamlines high-yield, customizable fluorescent RNA probe synthesis for sensitive in situ and Northern blot applications. This guide unpacks experimental workflows, actionable optimization strategies, and troubleshooting insights to maximize labeling efficiency and reproducibility in advanced RNA research.

• IWP-L6: High-Precision Porcupine Inhibitor for Wnt Pathway C

  2026-05-05

  IWP-L6 delivers unmatched sub-nanomolar Porcupine inhibition, empowering researchers to dissect the Wnt signaling pathway with exceptional specificity. From zebrafish regeneration models to ex vivo organ culture, this APExBIO tool redefines reproducibility and sensitivity in Wnt pathway research.

• Unidirectional Sarcomere Protein Turnover in Cardiomyocytes

  2026-05-04

  This study overturns the classic 'protein pool' model by demonstrating that sarcomere maintenance in cardiomyocytes follows a unidirectional replacement mechanism, where only newly synthesized proteins incorporate into the contractile apparatus as older ones are degraded. The findings refine our understanding of cardiac muscle homeostasis, with implications for protein turnover research and proteasome inhibitor assay design.

• UTP Solution (100 mM): Powering Precision in RNA and Metabol

  2026-05-04

  Explore how high-purity UTP Solution (100 mM) from APExBIO accelerates cutting-edge RNA synthesis and metabolic pathway studies. This thought-leadership article integrates mechanistic detail with actionable protocol guidance, drawing on recent advances in epigenetic regulation and translational research. The piece not only contextualizes UTP as a cornerstone nucleotide for in vitro transcription and galactose metabolism, but also charts a path for researchers to leverage robust nucleotide substrates to interrogate complex gene expression systems, such as the monogenic olfactory receptor selection illuminated by TRIM66.

• 5-Methyl-CTP: Elevating mRNA Vaccine Design and Translation

  2026-05-03

  This thought-leadership article explores how 5-Methyl-CTP, a 5-methyl modified cytidine triphosphate, is reshaping mRNA vaccine and therapeutic development by providing mechanistic stability and translational advantages. Drawing on both mechanistic insight and recent translational milestones—including robust mRNA vaccine protection in dairy cows against H5N1—this article offers actionable, evidence-based strategies for researchers optimizing in vitro transcription, gene expression studies, and mRNA drug development workflows. By synthesizing recent literature and strategic guidance, it demonstrates APExBIO’s leadership and expands the conversation beyond conventional product pages, arming translational scientists with deeper mechanistic understanding and practical implementation guidance.

• 5-Aminolevulinic acid HCl in Heme Biosynthesis Assays

  2026-05-02

  Uncover how 5-Aminolevulinic acid HCl transforms heme pathway and immune evasion research with robust solubility and precision. APExBIO’s high-purity reagent empowers reliable pathogen virulence assays and cancer imaging workflows.

• Pharmacokinetic/Pharmacodynamic Profiling of Tiamulin in Myc

  2026-05-02

  This study delivers the first detailed in vivo PK/PD characterization of Tiamulin (Thiamutilin) against Mycoplasma gallisepticum in poultry. By linking optimal AUC24h/MIC ratios with significant bacterial reduction, the research informs evidence-based dosing regimens and highlights the antibiotic’s role in controlling respiratory mycoplasmosis.

• Angiotensin 1/2 (5-7): Benchmarks for Renin-Angiotensin Rese

  2026-05-01

  Angiotensin 1/2 (5-7) is a high-purity peptide hormone essential for renin-angiotensin system research and blood pressure regulation. Recent studies confirm its robust vasoconstrictor activity and its role in enhancing SARS-CoV-2 spike protein–host receptor interactions. This article provides atomic evidence, protocol parameters, and cross-domain insights for advanced cardiovascular and viral pathogenesis workflows.

• Gastrin I (human): Reliable Tool for Advanced GI Assays

  2026-04-30

  This article provides scenario-driven guidance for biomedical researchers using Gastrin I (human) (SKU B5358) in cell-based and organoid assays. We address laboratory challenges in gastrointestinal physiology studies and demonstrate how APExBIO’s high-purity peptide ensures reproducibility and data quality. Protocol recommendations and evidence-based vendor comparisons help you select the right reagent for sensitive, translational research.

• Multi-Omics Mapping of ARID1A-Driven Resistance in Melanoma

  2026-04-30

  This study integrates multi-omics approaches to dissect resistance mechanisms to BRAF/MAPK inhibitors in melanoma, revealing ARID1A-dependent signaling rewiring and immune evasion. Identification of key resistance nodes such as PRKD1, JUN, and NCK1 highlights new avenues for overcoming therapeutic resistance in BRAF-mutant melanoma.

• Bazedoxifene Inhibits IL-6/GP130: Mechanistic Insights for O

  2026-04-29

  This review highlights Bazedoxifene's (BZA) novel role as an inhibitor of the IL-6/GP130 signaling pathway, a key driver of tumor progression and therapy resistance. The findings suggest BZA's potential for cancer therapy and provide a mechanistic rationale for repositioning this FDA-approved SERM in oncology.

• Disulfiram: Dopamine β-Hydroxylase Inhibitor in Cancer Resea

  2026-04-29

  Disulfiram is redefining cancer research by combining dopamine β-hydroxylase inhibition with potent, copper-enhanced proteasome inhibition. This article details workflow optimizations, practical troubleshooting, and assay design strategies to unlock Disulfiram's potential in apoptosis and synthetic lethality studies, especially in APC-deficient cancer models.

16214 records 1/1081 page Next 12345 下5页 Last page